Skip to content
NHLS WCA Number: 990000306648
  • Login to:
    • Thusano Portal
    • Proficiency Testing
    • Lab Results
    • WEB PTS Registration
    • CDW MicroStrategy
    • CSA
  • Staff Email
  • Contact Us
National Health Laboratory Service Logo National Health Laboratory Service Logo
  • Home
  • About Us
    • Overview
    • Board of Directors
    • Executive Management
    • Area Managers
    • Institutes & Subsidiaries
    • Laboratories
    • NHLS Achievements
    • Terms of Use
  • Our Services
    • Diagnostic
      • Type Of Tests
      • Diagnostic Media Products
      • Paternity Testing
      • MIC Testing
    • Academic Affairs and Research
      • Scope of Research
      • NHLS Research Trust
    • Training
    • Quality Assurance
      • Health Technology Assessment Unit
        • 2012-2021
        • 2022
        • 2023
        • 2024
        • 2025
      • Proficiency Testing
  • Priority Programmes
    • CD4
    • HIV Genotyping
    • HIV Viral Load
    • TB GeneXpert
    • Early Infant Diagnosis
  • Supply Chain
    • Latest RFQs
    • Latest Tender
    • Received Bids
    • Awarded Bids
    • Bid Cancellations
    • Bid Withdrawal
    • Awarded RFQ’s
    • RFQ Withdrawal
    • RFQ Cancellations
    • Archive
  • Key Documents
    • Annual Reports
    • Strategic Documents
    • paia
    • Acts and Bills
  • Media
    • Media Statements
    • NHLS in the News
    • Videos
    • Contact Us
  • Careers
    • Vacancies

testing

  1. Home
  2. testing
testing
Content Specialist2022-06-20T09:18:51+02:00

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

Content Specialist2022-06-20T09:18:51+02:00June 20th, 2022|0 Comments

Weiss S, Itri V, Pan R, Jiang X, Luo CC, Morris L, et al. Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines. Nat Commun. 2022;13(1):903.


Content Specialist2022-06-20T09:18:00+02:00

A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282

Content Specialist2022-06-20T09:18:00+02:00June 20th, 2022|0 Comments

Wilkin T, Chen H, Sahasrabuddhe V, Matining R, Mngqibisa R, Chinula L, et al. A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282. Clin Infect Dis. 2022.


Content Specialist2022-06-20T09:17:12+02:00

The Utility of Length of Mining Service and Latency in Predicting Silicosis among Claimants to a Compensation Trust

Content Specialist2022-06-20T09:17:12+02:00June 20th, 2022|0 Comments

Williams H, Ehrlich R, Barker S, Kisting-Cairncross S, Zungu M, Yassi A. The Utility of Length of Mining Service and Latency in Predicting Silicosis among Claimants to a Compensation Trust. Int J Environ Res Public Health. 2022;19(6).


Content Specialist2022-06-20T09:16:20+02:00

Association between viral suppression during the third trimester of pregnancy and unintended pregnancy among women on antiretroviral therapy: Results from the 2019 antenatal HIV Sentinel Survey, South Afric

Content Specialist2022-06-20T09:16:20+02:00June 20th, 2022|0 Comments

Woldesenbet S, Kufa T, Manda S, Ayalew K, Lombard C, Cheyip M, et al. Association between viral suppression during the third trimester of pregnancy and unintended pregnancy among women on antiretroviral therapy: Results from the 2019 antenatal HIV Sentinel Survey, South Africa. PLoS One. 2022;17(3):e0265124.


Content Specialist2022-06-20T09:15:28+02:00

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Content Specialist2022-06-20T09:15:28+02:00June 20th, 2022|0 Comments

Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437-46.


Content Specialist2022-06-20T09:09:58+02:00

The acidic tumour microenvironment: Manipulating the immune response to elicit escape

Content Specialist2022-06-20T09:09:58+02:00June 20th, 2022|0 Comments

Worsley CM, Veale RB, Mayne ES. The acidic tumour microenvironment: Manipulating the immune response to elicit escape. Hum Immunol. 2022;83(5):399-408.


Previous141516Next
Content Specialist2022-06-06T11:11:46+02:00June 6th, 2022|

Share This Post, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

Related Posts

Binocular Microscopes Incl 5 Year SLA – Tyg Hist E

Binocular Microscopes Incl 5 Year SLA – Tyg Hist E

Supply And Delivery Of A Fluke Probe Thermometer At NHLS Moses Kotane Laboratory

Supply And Delivery Of A Fluke Probe Thermometer At NHLS Moses Kotane Laboratory

Placement Of Chemistry And Immunoassay Analysers KZN Large And Medium Labs Including Service And Maintenance, And Reagent Deal For A Period Of Five (5) Years

Placement Of Chemistry And Immunoassay Analysers KZN Large And Medium Labs Including Service And Maintenance, And Reagent Deal For A Period Of Five (5) Years

Real-Time PCR Instrument, At NICD Sandringham, Johannesburg

Real-Time PCR Instrument, At NICD Sandringham, Johannesburg

South-to-south mentoring as a vehicle for implementing sustainable health security in Africa

South-to-south mentoring as a vehicle for implementing sustainable health security in Africa

REPORT FRAUD & CORRUPTION

Toll Free Number: 0800 000 552

SMS : 30916 (rates @ R1.50)
Email : nhls@thehotline.co.za
Free Fax : 086 726 1681

QUICK LINKS

National Biobank
SAVP
NICD
NIOH

SOCIAL MEDIA

NHLS

NICD

NIOH

PathReD

HEAD OFFICE

1 Modderfontein Road, Sandringham
Johannesburg, South Africa

Tel: 011-386-6000
Email: enquiries@nhls.ac.za
©2023 NHLS. All Rights Reserved. | Disclaimer | Terms of Use
Page load link
Go to Top